Delivery Order SPE2DB20D1110-SPE2DB25FK30J
- Not listed
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Ozempic 0.25-0.5 mg/dose pens (3ml) with a ceiling value of $5,885.48. This is a firm fixed-price delivery order with an ultimate completion date of September 17, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency awarded a delivery order valued at $6,266.60 to AmerisourceBergen Drug Corp for the supply of Ozempic (0.25-0.5 mg/dose) pens in 3ml quantities. This non-set-aside, competitively awarded contract utilizes firm fixed price terms and was executed on July 14, 2025, with completion targeted for July 15, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a...
- The Defense Logistics Agency awarded a $37,417.19 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Ozempic 0.25-0.5 mg/dose pens in 3 mL formulations, with completion targeted for September 15, 2025. This competitively awarded, non-set-aside contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's broader relationship...
- The Defense Logistics Agency awarded a $14,466.50 delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 0.25-0.5 mg/dose pens (3mL) on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price contract, which is not set aside for any specific category, represents a small-value transaction within AmerisourceBergen's broader federal pharmaceutical supply portfolio. The award was competitively awarded and will be performed at the vendor's corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $36,233.87 to AmerisourceBergen Drug Corp for the supply of Ozempic 0.25-0.5 mg/dose pens (3ml) on August 22, 2025, with completion scheduled for August 25, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $17,574.08 to AmerisourceBergen Drug Corp for the supply of Ozempic 0.25-0.5 mg/dose pens (3ml) on September 9, 2025, with completion targeted for September 10, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The pharmaceutical product will be supplied from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $10,550.33 to AmerisourceBergen Drug Corp for the supply of Ozempic (0.25-0.5 mg/dose pen, 3 mL) with a completion date of July 31, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is part of AmerisourceBergen's extensive pharmaceutical supply relationship with the federal government. The product will be delivered to the vendor's location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,729.87 for Ozempic 0.25-0.5 mg/dose pens (3 mL) with an ultimate completion date of May 9, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a continuation of pharmaceutical supply support under AmerisourceBergen's broader federal contracting...
- The Defense Logistics Agency awarded a $6,216.96 delivery order to AmerisourceBergen Drug Corp for Ozempic 0.25-0.5 mg/dose pens (3ml) with a completion date of June 2, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger pharmaceutical supply framework with DLA....
- The Defense Logistics Agency awarded a delivery order valued at $16,250.60 to AmerisourceBergen Drug Corp for the supply of Ozempic 0.25-0.5 mg/dose pens (3ml) under a firm fixed price contract. The award was made on August 14, 2025, with an ultimate completion date of August 15, 2025, and represents a non-competitive set-aside delivery order. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB20D1110Indefinite Delivery Contract
- SPE2DB20D1110-SPE2DB25FK30JDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 0.25-0.5 mg/dose pens (3ml) under a firm fixed-price contract. The order, valued at $6,363.37, is scheduled for completion by July 31, 2025, and will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded without set-aside designation and represents a single transaction within the company's broader federal pharmaceutical supply portfolio. This award is a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of medications, vaccines, and medical supplies to support military healthcare programs and other federal health systems, including the Defense Health Agency and U.S. Coast Guard. As a major pharmaceutical distributor, AmerisourceBergen maintains a significant capability to meet federal medical procurement requirements through competitive contracting and serves as a critical vendor for military and veteran healthcare supply chains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.4k | 7/30/25 |